Cargando…

Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology

BACKGROUND: Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of diabetes, which seriously affects the physical and mental health of patients. Sappan Lignum (SL) is effective in treating DPN. Previous reports have shown that SL has a clear hypoglycemic and anti-inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Xiaomin, Jin, De, Zhang, Yuqing, Zhou, Rongrong, Zhang, Yuehong, Lian, Fengmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263209/
https://www.ncbi.nlm.nih.gov/pubmed/34306139
http://dx.doi.org/10.1155/2021/5528018
_version_ 1783719341208895488
author Kang, Xiaomin
Jin, De
Zhang, Yuqing
Zhou, Rongrong
Zhang, Yuehong
Lian, Fengmei
author_facet Kang, Xiaomin
Jin, De
Zhang, Yuqing
Zhou, Rongrong
Zhang, Yuehong
Lian, Fengmei
author_sort Kang, Xiaomin
collection PubMed
description BACKGROUND: Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of diabetes, which seriously affects the physical and mental health of patients. Sappan Lignum (SL) is effective in treating DPN. Previous reports have shown that SL has a clear hypoglycemic and anti-inflammatory effect. However, the study of SL in the treatment of DPN is still limited and rare. OBJECTIVE: To investigate the mechanism of SL in the treatment of DPN based on network pharmacology. METHODS: The active ingredients of SL were screened by related databases. The compound targets were collected by the target prediction platforms. The DPN-related targets were gathered through disease databases. The intersection targets were obtained by uploading the compound targets and disease targets to Venny 2.1.0, and a compound-target network was constructed by Cytoscape3.7.2. The protein-protein interaction (PPI) relationships were obtained by the STRING11.0 database. Genome Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using the DAVID6.8 database. Molecular docking of key compounds and core targets was performed by DockThor. RESULTS: A total of 29 compounds and 51 intersection targets with potential therapeutic effects on DPN were obtained. The compound-target network construction resulted in four key compounds: protostemonine, 3-deoxysappanchalcone, 7,3′,4′-trihydroxy-3-benzyl-2H-chromene, and o-12′-methylergocornine. PPI network analysis yielded 10 core targets: AKT1, MAPK3, CXCL8, TNF, OPRM1, MTOR, STAT3, MAPK8, SIRT1, and HSP90AA1. KEGG analysis resulted in 82 signaling pathways (P < 0.05), including insulin resistance, HIF-1 signaling pathway, and type II diabetes. The docking results indicated that the main active compounds could stably bind to core targets. CONCLUSION: SL had the mechanism of multiple ingredients, multiple targets, and multiple pathways in the treatment of DPN. This study provided a scientific basis for further research on the treatment of DPN with SL and its extracts.
format Online
Article
Text
id pubmed-8263209
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-82632092021-07-22 Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology Kang, Xiaomin Jin, De Zhang, Yuqing Zhou, Rongrong Zhang, Yuehong Lian, Fengmei Evid Based Complement Alternat Med Research Article BACKGROUND: Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of diabetes, which seriously affects the physical and mental health of patients. Sappan Lignum (SL) is effective in treating DPN. Previous reports have shown that SL has a clear hypoglycemic and anti-inflammatory effect. However, the study of SL in the treatment of DPN is still limited and rare. OBJECTIVE: To investigate the mechanism of SL in the treatment of DPN based on network pharmacology. METHODS: The active ingredients of SL were screened by related databases. The compound targets were collected by the target prediction platforms. The DPN-related targets were gathered through disease databases. The intersection targets were obtained by uploading the compound targets and disease targets to Venny 2.1.0, and a compound-target network was constructed by Cytoscape3.7.2. The protein-protein interaction (PPI) relationships were obtained by the STRING11.0 database. Genome Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using the DAVID6.8 database. Molecular docking of key compounds and core targets was performed by DockThor. RESULTS: A total of 29 compounds and 51 intersection targets with potential therapeutic effects on DPN were obtained. The compound-target network construction resulted in four key compounds: protostemonine, 3-deoxysappanchalcone, 7,3′,4′-trihydroxy-3-benzyl-2H-chromene, and o-12′-methylergocornine. PPI network analysis yielded 10 core targets: AKT1, MAPK3, CXCL8, TNF, OPRM1, MTOR, STAT3, MAPK8, SIRT1, and HSP90AA1. KEGG analysis resulted in 82 signaling pathways (P < 0.05), including insulin resistance, HIF-1 signaling pathway, and type II diabetes. The docking results indicated that the main active compounds could stably bind to core targets. CONCLUSION: SL had the mechanism of multiple ingredients, multiple targets, and multiple pathways in the treatment of DPN. This study provided a scientific basis for further research on the treatment of DPN with SL and its extracts. Hindawi 2021-06-29 /pmc/articles/PMC8263209/ /pubmed/34306139 http://dx.doi.org/10.1155/2021/5528018 Text en Copyright © 2021 Xiaomin Kang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kang, Xiaomin
Jin, De
Zhang, Yuqing
Zhou, Rongrong
Zhang, Yuehong
Lian, Fengmei
Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology
title Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology
title_full Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology
title_fullStr Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology
title_full_unstemmed Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology
title_short Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology
title_sort systematic elucidation of the mechanism of sappan lignum in the treatment of diabetic peripheral neuropathy based on network pharmacology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263209/
https://www.ncbi.nlm.nih.gov/pubmed/34306139
http://dx.doi.org/10.1155/2021/5528018
work_keys_str_mv AT kangxiaomin systematicelucidationofthemechanismofsappanlignuminthetreatmentofdiabeticperipheralneuropathybasedonnetworkpharmacology
AT jinde systematicelucidationofthemechanismofsappanlignuminthetreatmentofdiabeticperipheralneuropathybasedonnetworkpharmacology
AT zhangyuqing systematicelucidationofthemechanismofsappanlignuminthetreatmentofdiabeticperipheralneuropathybasedonnetworkpharmacology
AT zhourongrong systematicelucidationofthemechanismofsappanlignuminthetreatmentofdiabeticperipheralneuropathybasedonnetworkpharmacology
AT zhangyuehong systematicelucidationofthemechanismofsappanlignuminthetreatmentofdiabeticperipheralneuropathybasedonnetworkpharmacology
AT lianfengmei systematicelucidationofthemechanismofsappanlignuminthetreatmentofdiabeticperipheralneuropathybasedonnetworkpharmacology